The Centers for Medicare & Medicaid Services (CMS) released information today about 10 drugs that would, after negotiations with drug companies, be covered at a significant discount for Medicare drug plan enrollees, starting in 2026. The negotiated drugs include those that are frequently dispensed as well as those that are the most expensive, and treat common conditions including cancer, diabetes, heart disease, and arthritis, according to CMS . The savings are significant.
Right now, Americans pay two to three times more for prescription drugs than they would anywhere else. But the Biden-Harris Administration beat Big Pharma. And after months of negotiations, Medicare has reached agreements to lower the price for 10 of the highest-cost drugs.
pic.twitter.com/eGVtAtJsVO “Congressional budget estimators predicted about $100 billion savings over 10 years from drug negotiations and a $3.
7 billion savings in the first year alone. Today we’re announcing that in our first year of negotiations we are saving Medicare an estimated $6 billion and Americans who pay out of pocket will be saving another $1.5 billion moving forward,” said the U.
S. Department of Health and Human Services (HHS) Secretary Xavier Becerra. What drugs will be discounted? Here is the list of drugs , the condition they treat, the 2026 pricing for a 30-day supply of each drug, and the discount off the list price: Conditions: Prevention and treatment of blood clots Negotiated price: $231 for a 30-day supply Di.